SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011783
Filing Date
2018-05-08
Accepted
2018-05-08 16:03:22
Documents
75
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20180331.htm 10-Q 1846497
2 EX-10.1 flxn-ex101_99.htm EX-10.1 44463
3 EX-31.1 flxn-ex311_6.htm EX-31.1 10021
4 EX-31.2 flxn-ex312_23.htm EX-31.2 10099
5 EX-32.1 flxn-ex321_7.htm EX-32.1 9098
6 GRAPHIC g201805081459468492166.jpg GRAPHIC 2733
  Complete submission text file 0001564590-18-011783.txt   6867990

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT flxn-20180331.xml EX-101.INS 1413778
8 XBRL TAXONOMY EXTENSION SCHEMA flxn-20180331.xsd EX-101.SCH 53800
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20180331_cal.xml EX-101.CAL 55431
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20180331_def.xml EX-101.DEF 170487
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20180331_lab.xml EX-101.LAB 421371
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20180331_pre.xml EX-101.PRE 321249
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 18814476
SIC: 2834 Pharmaceutical Preparations